Why This Matters
On July 13, 2026, a federal appeals court revived more than 500 lawsuits claiming that prenatal acetaminophen use caused autism or ADHD in children. Within hours, social media posts advising pregnant women to stop taking Tylenol were widely shared. Some posts suggested switching to ibuprofen or other pain relievers.
This is the wrong response. And it carries real clinical risk.
The ruling by the 2nd U.S. Circuit Court of Appeals in Manhattan was a procedural decision about evidence admissibility in litigation. The court explicitly stated it was "not deciding whether there is a general causal relationship between acetaminophen and ADHD and/or ASD." The ruling changed nothing about what medical science knows about acetaminophen in pregnancy. It changed nothing about clinical guidance. And it did nothing to make ibuprofen or naproxen safer, both of which are contraindicated in pregnancy and carry documented fetal risks that are substantially more serious than any association found in observational acetaminophen studies.
What We Know So Far
The legal history is complicated, but the medical guidance is not. Here is what happened:
The Tylenol autism litigation was consolidated into a federal multidistrict action with hundreds of cases. District Judge Denise L. Cote had previously granted summary judgment in favor of the defendants after excluding expert testimony from plaintiffs' experts, which effectively ended the litigation. On July 13, 2026, the 2nd U.S. Circuit Court of Appeals reversed that decision, ruling that the district court had improperly applied standards for excluding expert testimony. The appeals court sent the cases back to the district court for fresh consideration of the admissibility of plaintiffs' expert evidence.
This is an evidentiary ruling about courtroom procedure, not a scientific finding. As CNBC reported, Judge Calabresi's panel "stressed that the appeals court was not deciding whether using acetaminophen causes autism or ADHD."
Major medical organizations, including the American College of Obstetricians and Gynecologists (ACOG), the American Academy of Pediatrics (AAP), and SMFM (Society for Maternal-Fetal Medicine), continue to recommend acetaminophen as the safest available OTC medication for pain and fever management during pregnancy. That guidance has not changed.
Where the Risk Falls — If Acetaminophen Is Stopped
The greatest risk from this news cycle is not the lawsuit. It is the behavior it may prompt: pregnant women stopping acetaminophen, leaving fever untreated, or switching to contraindicated medications.
Fever in pregnancy is not benign. Body temperature above 102°F (38.9°C) during the first trimester is associated with an increased risk of neural tube defects, other fetal structural abnormalities, and adverse neurodevelopmental outcomes. The mechanism is well-established: sustained high body temperature in early pregnancy disrupts normal fetal brain and spinal cord development. This is not a theoretical risk. It is documented in multiple independent epidemiological studies.
In later pregnancy, untreated fever from illness can trigger preterm labor and is associated with neonatal complications. Managing fever with acetaminophen, which is effective and does not cross the placenta in harmful concentrations at standard doses, is the standard medical approach for a reason.
What Doctors and Experts Say
The observational studies that plaintiffs have cited in the Tylenol litigation, studies that found statistical associations between prenatal acetaminophen use and developmental outcomes, are not the kind of evidence that changes clinical practice. These are studies that show correlation, in populations where many factors simultaneously influence both the decision to take pain medication and the development of a child's neurology.
ACOG has repeatedly reviewed this literature and maintained its guidance. The key clinical consideration is straightforward: the documented risk of untreated fever to the developing fetus is greater than any hypothetical and as-yet unproven risk from the acetaminophen used to treat it.
What doctors do not want is for pregnant patients to stop acetaminophen, leave fevers above 102°F uncontrolled, and reach for an alternative. NSAIDs, including ibuprofen (Advil, Motrin) and naproxen (Aleve), are contraindicated in pregnancy, particularly in the second and third trimesters. Use of NSAIDs after 20 weeks of pregnancy is associated with fetal kidney problems, reduced amniotic fluid, and, in late pregnancy, premature closure of the ductus arteriosus, a cardiac structure in the fetus. These are not theoretical concerns. They are the reason NSAIDs now carry an FDA labeling warning for use during pregnancy from 20 weeks gestation forward.
What the Evidence Shows and What It Does Not
The observational studies cited in the Tylenol litigation find statistical associations between prenatal acetaminophen use and autism or ADHD diagnoses. Association is not causation. These studies cannot eliminate confounding: mothers who use more acetaminophen during pregnancy may be doing so. They are sicker. They have higher pain burdens because they have underlying conditions, or because of dozens of other factors that independently affect neurodevelopmental outcomes.
No randomized controlled trial has been conducted, and none could ethically be conducted in which pregnant women are randomly assigned to take or withhold acetaminophen to study autism outcomes. The absence of such a trial means the causal question cannot be resolved by existing data.
MedicalDaily Evidence Check
- Legal event: 2nd U.S. Circuit Court of Appeals ruling, July 13, 2026 — reversed exclusion of expert testimony; remanded to district court; explicitly did not rule on causation
- Medical guidance: Acetaminophen remains the recommended OTC pain and fever medication in pregnancy per ACOG, AAP, SMFM; guidance unchanged
- What the ruling shows: Expert testimony on this topic can proceed in court; cases are revived for further proceedings
- What the ruling does not prove: That acetaminophen causes autism or ADHD
-
What readers should know: Do not stop acetaminophen during pregnancy based on this news; do not switch to NSAIDs; discuss pain and fever management strategy with your OB
Who Faces the Greatest Risk?
Pregnant women who are most at risk from misinformed response to this lawsuit news include:
- First-trimester patients who may be most fearful of any potential fetal harm but who are also in the period when untreated fever poses the highest risk to developing neural structures
- Patients who follow social media health information closely and encounter posts advising avoidance of acetaminophen
- Patients managing chronic pain conditions in pregnancy who may feel pressured to stop all analgesics
-
Patients in communities where OB access is limited and who cannot quickly consult a provider about medication concerns
Symptoms and Warning Signs That Require Acetaminophen and Medical Evaluation
During pregnancy, these conditions require prompt action, including appropriate fever and pain management:
- Fever above 100.4°F (38°C) during pregnancy: contact your OB or midwife for guidance on management
- Fever above 102°F (38.9°C): treat immediately with acetaminophen at the recommended dose and seek same-day medical evaluation; do not wait
- Severe headache with fever and neck stiffness: seek emergency evaluation for meningitis risk
- Severe abdominal pain with fever: seek emergency evaluation
Do not take ibuprofen, naproxen, or aspirin for fever management during pregnancy without explicit guidance from your physician.
What You Can Do Now
- If you are pregnant and concerned about acetaminophen after seeing news about the lawsuit, call your OB's office. Most practices have nurses who can answer medication questions over the phone without an office visit.
- Do not stop or reduce acetaminophen doses for active fever or acute pain without speaking with your provider first.
- Ibuprofen, naproxen, and aspirin are not safe substitutes for acetaminophen in pregnancy. Do not use them without physician guidance.
- Use acetaminophen as directed on the label and only as needed. Chronic daily use at high doses is different from appropriate use to manage an acute fever or pain episode.
-
Ask your OB at your next prenatal appointment to review your approach to pain and fever management for the rest of your pregnancy.
Cost and Access: What Patients Should Know
Acetaminophen (generic) is widely available over the counter at every pharmacy and most grocery stores, typically for under $10 per bottle. The standard adult dose during pregnancy, as recommended by most OBs, is 325 to 500 mg every 4 to 6 hours as needed, not exceeding 3,000 to 4,000 mg in 24 hours.
ACOG's patient FAQ on acetaminophen in pregnancy is freely available at ACOG.org and can be accessed without a membership or login. For patients without an OB, community health centers and Planned Parenthood locations that provide prenatal care can answer medication questions.
What Happens Next
The Tylenol autism litigation will now return to district court for re-evaluation of expert testimony admissibility. That process will take months to years. If the expert testimony is ultimately admitted, a jury trial or trials would follow. None of that timeline changes current clinical guidance.
MedicalDaily will continue monitoring the litigation and will report if any regulatory agency changes its guidance on acetaminophen in pregnancy based on new evidence.
The Bottom Line
The July 13, 2026 appeals court ruling reviving Tylenol autism lawsuits is a legal and procedural development, not a medical or scientific one. The court did not find that acetaminophen causes autism. Major medical organizations continue to recommend acetaminophen as the safest OTC option for pain and fever in pregnancy, and that guidance has not changed. Untreated fever above 102°F in pregnancy poses documented risks to fetal development. NSAIDs are contraindicated in pregnancy and are not a safe substitute. If you are pregnant and concerned, call your OB — not a social media post.
